bf/NASDAQ:EGRX_icon.png

NASDAQ:EGRX

Eagle Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.96

01/05 20:00

Market Cap

78.44M

Beta: 0.91

Volume Today

470

Avg: 153.65K

PE Ratio

4.72

PFCF: −7.76

    Description

    Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymph...Show More

    Earnings

    Earnings per Share (Estimate*)

    12342020-05-112022-05-092024-03-142024-05-222024-08-13

    Revenue (Estimate*)

    20M40M60M80M100M120M2020-05-112022-05-092024-03-142024-05-222024-08-13

    *Estimate based on analyst consensus